Hyperfine (Hyperfine) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Hyperfine Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Hyperfine is: No Data: Cannot be evaluated.

Competitive Comparison of Hyperfine's Risk Assessment

For the Medical Devices subindustry, Hyperfine's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyperfine's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hyperfine's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Hyperfine's Risk Assessment falls into.

Hyperfine (NAS:HYPR) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Hyperfine Risk Assessment Related Terms

Thank you for viewing the detailed overview of Hyperfine's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyperfine (Hyperfine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hyperfine Inc (NAS:HYPR) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

351 New Whitfield Street, Guilford, CT, USA, 06437

Website

https://www.hyperfine.io

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. Legacy Hyperfine and Liminal represent two operating segments of the company. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Executives

Thomas Teisseyre	officer: Chief Operating Officer	C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Khan Siddiqui	officer: See Remarks	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Brett Hale	officer: Chief Administrative Officer	C/O HYPERFINE, INC., 351 NEW WHITFIELD STREET, GUILFORD CT 06437
Maria Sainz	director	C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Jonathan M Rothberg	director, 10 percent owner	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Alok Gupta	officer: Chief Financial Officer	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Neela Paykel	officer: Gen Counsel & Corp Secretary	530 OLD WHITFIELD STREET, GUILFORD CT 06437
David D Scott	director, officer: President and CEO	530 OLD WHITFIELD STREET, GUILFORD CT 06437
Ruth A Fattori	director	1303 EAST ALGONQUIN ROAD, SCHAUMBURG IL 60196
Hc Sponsor Llc	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, 28TH FLOOR, NEW YORK NY 10001
Arthur Bruce Cohen	10 percent owner	12 SOUTH MAIN STREET, SUITE #203, NORWALK CT 06854
Healthcor Group, Llc	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
Joseph Patrick Healey	10 percent owner	31 HUDSON YARDS, 10TH FLOOR, NEW YORK NY 10001
R Scott Huennekens	director	C/O VOLCANO CORPORATION, 11455 EL CAMINO REAL, SUITE 460, SAN DIEGO CA 92130
Scott A. White	officer: Chief Commercial Officer	530 OLD WHITFIELD STREET, GUILFORD CT 06437